{"id":34258,"date":"2022-09-19T15:05:37","date_gmt":"2022-09-19T07:05:37","guid":{"rendered":"http:\/\/biopioneer.com.tw\/?p=34258"},"modified":"2025-06-30T18:20:14","modified_gmt":"2025-06-30T10:20:14","slug":"3x-dykddddk-peptide-cas-402750-12-3-apexbio-%e8%b2%a8%e8%99%9fa6001","status":"publish","type":"post","link":"http:\/\/biopioneer.com.tw\/?p=34258","title":{"rendered":"3X (DYKDDDDK) Peptide | CAS# 402750-12-3 APExBIO  \u8ca8\u865fA6001"},"content":{"rendered":"<p><strong><span style=\"font-size: 12pt; color: #ff6600;\"><span style=\"font-size: 14pt;\"><span style=\"color: #800080;\">\u751f\u5316\u5206\u6790\u8a66\u5291\u7cfb\u5217\u5546\u54c1-&gt;&gt;<span style=\"color: #ff6600;\">3X (DYKDDDDK) Peptide<\/span><\/span><\/span><\/span><\/strong><\/p>\n<p>APExBIO Technology LLC \u662f\u4e00\u5bb6\u9818\u5148\u7684\u5c0f\u5206\u5b50\u6291\u5236\u5291 (Small Molecule Inhibitors)\/\u6d3b\u5316\u5291(Activators)\u3001\u5316\u5408\u7269\u5eab( Compound Libraries)\u3001\u80dc\u80bd(Peptides)\u3001\u6aa2\u6e2c\u8a66\u5291\u76d2(Assay Kits)\u3001\u87a2\u5149\u6a19\u8a18(Fluorescent Label)\u3001\u9176(Enzymes)\u3001\u4fee\u98fe\u6838\u82f7\u9178(Modified Nucleotides)\u3001mRNA \u5408\u6210\u4ee5\u53ca\u5404\u7a2e\u5206\u5b50\u751f\u7269\u5b78\u5de5\u5177\u7684\u4f9b\u61c9\u5546\u3002APExBIO\u63d0\u4f9b\u5ee3\u6cdb\u7684\u7522\u54c1\u7dda\uff0c\u6db5\u84cb 20 \u591a\u500b\u4e0d\u540c\u7684\u7814\u7a76\u9818\u57df\uff0c\u4f8b\u5982\u764c\u75c7(cancer)\u3001\u514d\u75ab\u5b78(immunology)\u3001\u795e\u7d93\u79d1\u5b78(neurosciences)\u3001\u7d30\u80de\u51cb\u4ea1(apoptosis)\u548c\u8868\u89c0\u907a\u50b3\u5b78(epigenetics)\u7b49\u3002\u516c\u53f8\u7e3d\u90e8\u4f4d\u65bc\u7f8e\u570b\u5fb7\u5dde\u4f11\u58eb\u9813USA (Houston, Texas)\uff0c\u81f4\u529b\u65bc\u670d\u52d9\u5168\u7403\u5ba2\u6236\u3002\u9ad8\u5ea6\u91cd\u8996\u7522\u54c1\u54c1\u8cea\u3002\u6240\u6709\u7522\u54c1\u5747\u9075\u5faa\u56b4\u683c\u7684\u751f\u7522\u6307\u5357\uff0c\u4e26\u9644\u6709\u5206\u6790\u8b49\u66f8\u3001HPLC\u3001\u8cea\u8b5c(Mass Spectrum)\u548cHMNR\u4ee5\u53ca\u9ad4\u5916\u9a57\u8b49(in vitro validation)\u3002 APExBIO\u7522\u54c1\u5df2\u88ab\u300aNature\u300b\u3001\u300aCell\u300b\u548c\u300aScience\u300b\u7b49\u773e\u591a\u9802\u7d1a\u540c\u884c\u8a55\u5be9\u671f\u520a\u5f15\u7528\u3002<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"\" src=\"https:\/\/biopioneer.com.tw\/wp-content\/uploads\/downloads\/2025\/06\/%E5%A4%AA%E9%BC%8E-APExBIO-Technology-LLC-%E5%93%81%E7%89%8C.png\" width=\"1099\" height=\"274\" \/><\/p>\n<p><span style=\"color: #00ccff;\"><a style=\"color: #00ccff;\" href=\"http:\/\/biopioneer.com.tw\/?p=34258\"><span style=\"color: #33cccc;\"><strong><span style=\"font-size: 12pt;\">3X (DYKDDDDK) Peptide | CAS# 402750-12-3 APExBIO\u00a0 \u8ca8\u865fA6001<\/span><\/strong><\/span><\/a><\/span><\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"\" src=\"https:\/\/www.apexbt.com\/pub\/media\/prod_images\/a\/6\/a6001.png\" alt=\"\" width=\"218\" height=\"251\" \/><\/p>\n<p>DYKDDDDK-tag \u7cfb\u7d71\u4f7f\u7528\u4e00\u500b\u77ed\u7684\u3001\u5177\u89aa\u6c348 \u6c28\u57fa\u9178\u80bd(8- amino-acid peptide)\uff0c\u8207\u76ee\u6a19\u86cb\u767d\u8cea\u878d\u5408\u3002 DYKDDDDK \u80bd\u8207\u6297\u9ad4 M1 \u7d50\u5408\u3002\u8a72\u7cfb\u7d71\u7684\u4e00\u500b\u7f3a\u9ede\u662f\u55ae\u514b\u9686\u6297\u9ad4\u7d14\u5316\u57fa\u8cea\u4e0d\u5982\u5176\u4ed6\u7d14\u5316\u57fa\u8cea\u7a69\u5b9a\u3002\u4e00\u822c\u4f86\u8aaa\uff0c\u5c0f\u6a19\u7c64\u53ef\u4ee5\u7528\u7279\u7570\u6027\u55ae\u514b\u9686\u6297\u9ad4\u6aa2\u6e2c\u3002\u70ba\u4e86\u6539\u9032\u5c0d DYKDDDDK \u6a19\u7c64\u7684\u6aa2\u6e2c\uff0c\u958b\u767c\u4e86 3x (DYKDDDDK) \u7cfb\u7d71\u3002\u9019\u500b\u4e09\u4e32\u806f DYKDDDDK \u8868\u4f4d\u662f\u89aa\u6c34\u7684\uff0c22 \u500b\u6c28\u57fa\u9178\u9577\uff0c\u53ef\u4ee5\u6aa2\u6e2c\u9ad8\u9054 10 fmol \u7684\u8868\u9054\u878d\u5408\u86cb\u767d\u3002 Pyrococcus furiosus \u7684 DYKDDDDK \u6a19\u8a18\u7684\u9ea5\u82bd\u7cd6\u7cca\u7cbe\u7d50\u5408\u86cb\u767d\u7d50\u6676 \uff0c\u6676\u9ad4\u7684\u8cea\u91cf\u8207\u672a\u6a19\u8a18\u86cb\u767d\u8cea\u7684\u6676\u9ad4\u975e\u5e38\u76f8\u4f3c\u3002\u6700\u5f8c\uff0c\u53ef\u4ee5\u901a\u904e\u8178\u6fc0\u9176\u8655\u7406\u53bb\u9664 DYKDDDDK \u6a19\u7c64\uff0c\u8178\u6fc0\u9176\u5c0d\u80bd\u5e8f\u5217\u7684\u4e94\u500b C \u672b\u7aef\u6c28\u57fa\u9178\u5177\u6709\u7279\u7570\u6027\u3002<\/p>\n<ul>\n<li>1. Wei Yuan, Qais Al-Hadid, et al. &#8220;TDRD3 promotes DHX9 chromatin recruitment and R-loop resolution.&#8221; Nucleic Acids Res. 2021 Sep 7;49(15):8573-8591.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34329467\">PMID:34329467<\/a><\/li>\n<li>2. Daniel L. Kober, Arun Radhakrishnan, et al. &#8220;Scap structures highlight key role for rotation of intertwined luminal loops in cholesterol sensing.&#8221; Cell. 2021 Jul 8;184(14):3689-3701.e22.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34139175\">PMID:34139175<\/a><\/li>\n<li>3. Haijing Guo, Jen-Hsuan Wei, et al. &#8220;Importin \u03b1 phosphorylation promotes TPX2 activation by GM130 to control astral microtubules and spindle orientation.&#8221; J Cell Sci. 2021 Feb 19;134(4):jcs258356.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33526712\">PMID:33526712<\/a><\/li>\n<li>4. Wu Y, Jin S, et al. &#8220;Selective autophagy controls the stability of transcription factor IRF3 to balance type I interferon production and immune suppression.&#8221; Autophagy. 2020;1-14.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32476569\">PMID:32476569<\/a><\/li>\n<li>5. Howard SM, Ceppi I, et al. &#8220;The internal region of CtIP negatively regulates DNA end resection.&#8221; Nucleic Acids Res. 2020;48(10):5485-5498.\u00a0<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32347940\">PMID:32347940<\/a><\/li>\n<li>6. Jesse R. Poganik, Alexandra K. Van Hall-Beauvais, et al. &#8220;The mRNA-binding protein HuR is a kinetically-privileged electrophile sensor.&#8221; Helvetica Chimica Acta.10.1002.<\/li>\n<\/ul>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"\" src=\"http:\/\/biopioneer.com.tw\/wp-content\/uploads\/downloads\/2022\/09\/A6001_49.jpg\" alt=\"\" width=\"532\" height=\"412\" \/><\/p>\n<table>\n<tbody>\n<tr>\n<td>Storage<\/td>\n<td>Desiccate at -20\u00b0C<\/td>\n<\/tr>\n<tr>\n<td>M.Wt<\/td>\n<td>2861.87<\/td>\n<\/tr>\n<tr>\n<td>Cas No.<\/td>\n<td>402750-12-3<\/td>\n<\/tr>\n<tr>\n<td>Formula<\/td>\n<td>C<sub>120<\/sub>H<sub>169<\/sub>N<sub>31<\/sub>O<sub>49<\/sub>S<\/td>\n<\/tr>\n<tr>\n<td>Synonyms<\/td>\n<td>H-Met-Asp-Tyr-Lys-Asp-His-Asp-Gly-Asp-Tyr-Lys-Asp-His-Asp-Ile-Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys-OH<\/td>\n<\/tr>\n<tr>\n<td>Solubility<\/td>\n<td>\u226525mg\/ml in TBS (0.5M Tris-HCl, pH 7.4, with 1M NaCl), 1X TBS as recommended buffer.<\/td>\n<\/tr>\n<tr>\n<td>Chemical Name<\/td>\n<td>3X (DYKDDDDK) Peptide<\/td>\n<\/tr>\n<tr>\n<td>SDF<\/td>\n<td><a href=\"https:\/\/www.apexbt.com\/downloader\/sdf\/A6001.sdf\">Download SDF<\/a><\/td>\n<\/tr>\n<tr>\n<td>Shipping Condition<\/td>\n<td>Ship with blue ice, or upon other requests.<\/td>\n<\/tr>\n<tr>\n<td>General tips<\/td>\n<td>For obtaining a higher solubility, please warm the tube at 37\u00b0C and shake it in the ultrasonic bath for a while. We do not recommend long-term storage for the solution, please use it up soon.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><\/h2>\n<h2><span style=\"font-size: 12pt;\"><a href=\"http:\/\/www.apexbt.com\/\"><img decoding=\"async\" loading=\"lazy\" class=\"\" src=\"http:\/\/biopioneer.com.tw\/wp-content\/uploads\/downloads\/2022\/09\/A6001_45.jpg\" alt=\"\" width=\"549\" height=\"423\" \/><\/a><\/span><\/h2>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"\" src=\"http:\/\/biopioneer.com.tw\/wp-content\/uploads\/downloads\/2022\/09\/A6001_46.jpg\" alt=\"\" width=\"548\" height=\"445\" \/><\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"\" src=\"http:\/\/biopioneer.com.tw\/wp-content\/uploads\/downloads\/2022\/09\/A6001_47.jpg\" alt=\"\" width=\"579\" height=\"450\" \/><\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"\" src=\"http:\/\/biopioneer.com.tw\/wp-content\/uploads\/downloads\/2022\/09\/A6001_48.jpg\" alt=\"\" width=\"558\" height=\"448\" \/><\/p>\n<h4><\/h4>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"\" src=\"http:\/\/biopioneer.com.tw\/wp-content\/uploads\/2022\/12\/%E5%93%81%E7%89%8C%E7%B9%AA%E5%9C%96-Apexbio_%E5%B7%A5%E4%BD%9C%E5%8D%80%E5%9F%9F-1-300x300.jpg\" width=\"203\" height=\"225\" \/><\/p>\n<p><a href=\"http:\/\/www.apexbt.com\/\"><span style=\"font-size: 14pt; color: #ff6600;\"><strong><span style=\"color: #800080;\"><span style=\"font-size: 14pt;\">APExBIO\u53f0\u7063\u4ee3\u7406\u5546:\u00a0 <\/span><\/span><\/strong><\/span><\/a><span style=\"font-size: 14pt;\"><a href=\"https:\/\/www.apexbt.com\/\"><span style=\"color: #ff99cc;\"><span style=\"color: #ff6600;\">https:\/\/www.apexbt.com\/<\/span><\/span><\/a><\/span><\/p>\n<p>APExBIO\u63d0\u4f9b\u512a\u8cea\u7684\u80dc\u80bd\u548c\u751f\u7269\u5206\u6790\u8a66\u5291\uff0c\u5ee3\u6cdb\u7522\u54c1\u7dda\u5982Protease\u3001Chromatin\/Epigenetics\u8868\u89c0\u907a\u50b3\u5b78\u3001MAPK Signal\u3001DNA Damege\/DNA repair\u3001\u7d30\u80de\u51cb\u4ea1\u3001\u816b\u7624\u751f\u7269\u5b78\u3001Stem cell\u7b49\u7814\u7a76\u9818\u57df\uff0c \u9084\u63d0\u4f9b\u5b9a\u5236\u7684\u670d\u52d9\uff0c\u5305\u62ec\u591a\u80bd\u5408\u6210\uff0c\u6297\u9ad4\u7684\u751f\u7522\u548c\u6aa2\u6e2c\u7684\u767c\u5c55\u3002\u7522\u54c1\u7ddaDNA\/RNA prep kit\u3001Drug Screening panel\u3001Bioactive peptides\u3001Growth factors\u3001Biotinylation Reagents\u3001tag peptides\u3001amino Acids\u3001Growth factors\u7b49\u3002APExBIO\u7522\u54c1\u8cea\u91cf\u90fd\u4f34\u96a8\u8457\u8b49\u66f8\u7684\u5206\u6790\uff0c\u9ad8\u6548\u6db2\u76f8\u8272\u8b5c\uff0c\u8cea\u8b5c\uff0c\u548cHMNR\u6578\u64da\u3002<\/p>\n<p><img decoding=\"async\" loading=\"lazy\" class=\"\" src=\"http:\/\/biopioneer.com.tw\/wp-content\/uploads\/2024\/09\/line-2_%E5%B7%A5%E4%BD%9C%E5%8D%80%E5%9F%9F-1.jpg\" width=\"302\" height=\"230\" \/><\/p>\n<table width=\"1088\">\n<tbody>\n<tr>\n<td width=\"96\">A2601<\/td>\n<td width=\"375\">Aclacinomycin A<\/td>\n<td width=\"159\">57576-44-0<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Topoisomerase I and II inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2602<\/td>\n<td width=\"375\">Calpain Inhibitor I, ALLN<\/td>\n<td width=\"159\">110044-82-1<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Calpain I\/II\/ B\/L inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2603<\/td>\n<td width=\"375\">Calpain Inhibitor II, ALLM<\/td>\n<td width=\"159\">136632-32-1<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Calpain inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2604<\/td>\n<td width=\"375\">Celastrol<\/td>\n<td width=\"159\">34157-83-0<\/td>\n<td width=\"79\">98.67%<\/td>\n<td width=\"380\">Antioxidant, anti-inflammatory and immunosuppressive agent<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2606<\/td>\n<td width=\"375\">Epoxomicin<\/td>\n<td width=\"159\">134381-21-8<\/td>\n<td width=\"79\">97.92%<\/td>\n<td width=\"380\">Proteasome inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2610<\/td>\n<td width=\"375\">Fenbendazole<\/td>\n<td width=\"159\">43210-67-9<\/td>\n<td width=\"79\">99.57%<\/td>\n<td width=\"380\">For pinworm treatment in animals<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2612<\/td>\n<td width=\"375\">MG-115<\/td>\n<td width=\"159\">133407-86-0<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Potent reversible proteasome inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2614<\/td>\n<td width=\"375\">Bortezomib (PS-341)<\/td>\n<td width=\"159\">179324-69-7<\/td>\n<td width=\"79\">99.89%<\/td>\n<td width=\"380\">Proteasome Inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2623<\/td>\n<td width=\"375\">VU 0364439<\/td>\n<td width=\"159\">1246086-78-1<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Positive allosteric mGluR-4 modulator<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2633<\/td>\n<td width=\"375\">Brivanib Alaninate (BMS-582664)<\/td>\n<td width=\"159\">649735-63-7<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">VEGFR2 inhibitor,ATP-competitive<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2664<\/td>\n<td width=\"375\">VX-661<\/td>\n<td width=\"159\">1152311-62-0<\/td>\n<td width=\"79\">99.88%<\/td>\n<td width=\"380\">F508del CFTR corrector<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2673<\/td>\n<td width=\"375\">AG-1024<\/td>\n<td width=\"159\">65678-07-1<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Selective IGF-1R inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2678<\/td>\n<td width=\"375\">SU11274<\/td>\n<td width=\"159\">658084-23-2<\/td>\n<td width=\"79\">\u226595.00%<\/td>\n<td width=\"380\">C-Met inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2681<\/td>\n<td width=\"375\">TGX-221<\/td>\n<td width=\"159\">663619-89-4<\/td>\n<td width=\"79\">98.91%<\/td>\n<td width=\"380\">PI3K\u03b2 inhibitor,potent,selective and ATP competitive<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2689<\/td>\n<td width=\"375\">Butein<\/td>\n<td width=\"159\">487-52-5<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Protein kinase inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2700<\/td>\n<td width=\"375\">10Panx<\/td>\n<td width=\"159\">955091-53-9<\/td>\n<td width=\"79\">99.29%<\/td>\n<td width=\"380\">Panx-1 mimetic inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2701<\/td>\n<td width=\"375\">Scrambled 10Panx<\/td>\n<td width=\"159\">1315378-72-3<\/td>\n<td width=\"79\">98.68%<\/td>\n<td width=\"380\">Panx-1 mimetic inhibitory peptide, blocks pannexin-1 gap junctions<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2754<\/td>\n<td width=\"375\">TG100-115<\/td>\n<td width=\"159\">677297-51-7<\/td>\n<td width=\"79\">98.02%<\/td>\n<td width=\"380\">PI3K\u03b3\/PI3K\u03b4 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2782<\/td>\n<td width=\"375\">Amonafide<\/td>\n<td width=\"159\">69408-81-7<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">DNA intercalator,Topo II inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2806<\/td>\n<td width=\"375\">BX-912<\/td>\n<td width=\"159\">702674-56-4<\/td>\n<td width=\"79\">95.55%<\/td>\n<td width=\"380\">PDK1 inhibitor,potent and ATP-competitive<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2813<\/td>\n<td width=\"375\">Ivermectin<\/td>\n<td width=\"159\">70288-86-7<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">NAChR\/purinergic P2X4 receptor modulator<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2822<\/td>\n<td width=\"375\">AC480 (BMS-599626)<\/td>\n<td width=\"159\">714971-09-2<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">HER1\/2 inhibitor,selective and efficacious<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2838<\/td>\n<td width=\"375\">OSI-930<\/td>\n<td width=\"159\">728033-96-3<\/td>\n<td width=\"79\">99.58%<\/td>\n<td width=\"380\">Inhibitor of Kit, KDR, Flt, CSF-1R, c-Raf and Lck<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2842<\/td>\n<td width=\"375\">Melatonin<\/td>\n<td width=\"159\">73-31-4<\/td>\n<td width=\"79\">99.81%<\/td>\n<td width=\"380\">Melatonin receptors agonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2845<\/td>\n<td width=\"375\">Omeprazole<\/td>\n<td width=\"159\">73590-58-6<\/td>\n<td width=\"79\">97.37%<\/td>\n<td width=\"380\">H+,K+-ATPase inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2846<\/td>\n<td width=\"375\">OSU-03012 (AR-12)<\/td>\n<td width=\"159\">742112-33-0<\/td>\n<td width=\"79\">99.43%<\/td>\n<td width=\"380\">Potent PDK1 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2852<\/td>\n<td width=\"375\">Leflunomide<\/td>\n<td width=\"159\">75706-12-6<\/td>\n<td width=\"79\">99.69%<\/td>\n<td width=\"380\">AHR agonist,immunosuppressive agent<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2884<\/td>\n<td width=\"375\">Doxazosin Mesylate<\/td>\n<td width=\"159\">77883-43-3<\/td>\n<td width=\"79\">99.82%<\/td>\n<td width=\"380\">\u03b11-adrenergic receptor antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2890<\/td>\n<td width=\"375\">Nepafenac<\/td>\n<td width=\"159\">78281-72-8<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">COX-1 and COX-2 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2917<\/td>\n<td width=\"375\">Flumazenil<\/td>\n<td width=\"159\">78755-81-4<\/td>\n<td width=\"79\">99.85%<\/td>\n<td width=\"380\">Benzodiazepine antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2942<\/td>\n<td width=\"375\">Masitinib (AB1010)<\/td>\n<td width=\"159\">790299-79-5<\/td>\n<td width=\"79\">99.60%<\/td>\n<td width=\"380\">Tyrosine kinase inhibitor, potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2949<\/td>\n<td width=\"375\">Linifanib (ABT-869)<\/td>\n<td width=\"159\">796967-16-3<\/td>\n<td width=\"79\">99.62%<\/td>\n<td width=\"380\">VEGFR\/PDGFR inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2960<\/td>\n<td width=\"375\">Loratadine<\/td>\n<td width=\"159\">79794-75-5<\/td>\n<td width=\"79\">98.24%<\/td>\n<td width=\"380\">Peripheral HH1R antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2974<\/td>\n<td width=\"375\">Foretinib (GSK1363089)<\/td>\n<td width=\"159\">849217-64-7<\/td>\n<td width=\"79\">98.36%<\/td>\n<td width=\"380\">VEGF and HGF receptor inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2977<\/td>\n<td width=\"375\">Cabozantinib (XL184, BMS-907351)<\/td>\n<td width=\"159\">849217-68-1<\/td>\n<td width=\"79\">98.60%<\/td>\n<td width=\"380\">VEGFR2\/Met\/Ret\/Kit\/FLT\/\/AXL inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A2986<\/td>\n<td width=\"375\">ADL5859 HCl<\/td>\n<td width=\"159\">850173-95-4<\/td>\n<td width=\"79\">99.16%<\/td>\n<td width=\"380\">\u03b4-opioid receptor agonist,selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3001<\/td>\n<td width=\"375\">PCI-32765 (Ibrutinib)<\/td>\n<td width=\"159\">936563-96-1<\/td>\n<td width=\"79\">99.39%<\/td>\n<td width=\"380\">Bruton&#8217;s tyrosine kinase (BTK) inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3002<\/td>\n<td width=\"375\">ABT-888 (Veliparib)<\/td>\n<td width=\"159\">912444-00-9<\/td>\n<td width=\"79\">99.87%<\/td>\n<td width=\"380\">Potent PARP inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3003<\/td>\n<td width=\"375\">MDV3100 (Enzalutamide)<\/td>\n<td width=\"159\">915087-33-1<\/td>\n<td width=\"79\">99.78%<\/td>\n<td width=\"380\">Androgen receptor antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3004<\/td>\n<td width=\"375\">Vemurafenib (PLX4032, RG7204)<\/td>\n<td width=\"159\">918504-65-1<\/td>\n<td width=\"79\">98.48%<\/td>\n<td width=\"380\">BRAF kinase inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3005<\/td>\n<td width=\"375\">CAL-101 (Idelalisib, GS-1101)<\/td>\n<td width=\"159\">870281-82-6<\/td>\n<td width=\"79\">99.91%<\/td>\n<td width=\"380\">PI3K inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3006<\/td>\n<td width=\"375\">GDC-0068 (RG7440)<\/td>\n<td width=\"159\">1001264-89-6<\/td>\n<td width=\"79\">99.06%<\/td>\n<td width=\"380\">Pan-AKT inhibitor,highly selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3007<\/td>\n<td width=\"375\">ABT-263 (Navitoclax)<\/td>\n<td width=\"159\">923564-51-6<\/td>\n<td width=\"79\">98.02%<\/td>\n<td width=\"380\">Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3008<\/td>\n<td width=\"375\">Y-27632 dihydrochloride<\/td>\n<td width=\"159\">146986-50-7;129830-38-2<\/td>\n<td width=\"79\">99.08%<\/td>\n<td width=\"380\">ROCK1 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3009<\/td>\n<td width=\"375\">Sorafenib<\/td>\n<td width=\"159\">284461-73-0<\/td>\n<td width=\"79\">99.87%<\/td>\n<td width=\"380\">Raf kinases and tyrosine kinases inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3010<\/td>\n<td width=\"375\">MK-2206 dihydrochloride<\/td>\n<td width=\"159\">1032350-13-2<\/td>\n<td width=\"79\">99.59%<\/td>\n<td width=\"380\">Akt1\/2\/3 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3011<\/td>\n<td width=\"375\">CHIR-99021 (CT99021)<\/td>\n<td width=\"159\">252917-06-9<\/td>\n<td width=\"79\">98.32%<\/td>\n<td width=\"380\">GSK-3 inhibitor, Cell-permeable, ATP-competitive<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3012<\/td>\n<td width=\"375\">Ruxolitinib (INCB018424)<\/td>\n<td width=\"159\">941678-49-5<\/td>\n<td width=\"79\">99.64%<\/td>\n<td width=\"380\">JAK inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3013<\/td>\n<td width=\"375\">PD0325901<\/td>\n<td width=\"159\">391210-10-9<\/td>\n<td width=\"79\">99.74%<\/td>\n<td width=\"380\">MEK inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3014<\/td>\n<td width=\"375\">BGJ398<\/td>\n<td width=\"159\">872511-34-7<\/td>\n<td width=\"79\">99.74%<\/td>\n<td width=\"380\">FGFR inhibitor ,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3015<\/td>\n<td width=\"375\">BKM120<\/td>\n<td width=\"159\">944396-07-0<\/td>\n<td width=\"79\">98.01%<\/td>\n<td width=\"380\">Inhibitor of pan-Class I PI3K<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3016<\/td>\n<td width=\"375\">PLX-4720<\/td>\n<td width=\"159\">918505-84-7<\/td>\n<td width=\"79\">98.70%<\/td>\n<td width=\"380\">BRAF kinase inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3017<\/td>\n<td width=\"375\">Dasatinib (BMS-354825)<\/td>\n<td width=\"159\">302962-49-8<\/td>\n<td width=\"79\">98.09%<\/td>\n<td width=\"380\">Src and BCR-Abl inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3018<\/td>\n<td width=\"375\">Trametinib (GSK1120212)<\/td>\n<td width=\"159\">871700-17-3<\/td>\n<td width=\"79\">98.98%<\/td>\n<td width=\"380\">MEK1 and MEK2 inhibitor, potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3019<\/td>\n<td width=\"375\">AT-406 (SM-406)<\/td>\n<td width=\"159\">1071992-99-8<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">IAP inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3021<\/td>\n<td width=\"375\">GDC-0449 (Vismodegib)<\/td>\n<td width=\"159\">879085-55-9<\/td>\n<td width=\"79\">99.64%<\/td>\n<td width=\"380\">Hedgehog antagonist,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3022<\/td>\n<td width=\"375\">Pazopanib (GW-786034)<\/td>\n<td width=\"159\">444731-52-6<\/td>\n<td width=\"79\">98.81%<\/td>\n<td width=\"380\">VEGFR\/PDGFR\/FGFR inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3023<\/td>\n<td width=\"375\">P005091<\/td>\n<td width=\"159\">882257-11-6<\/td>\n<td width=\"79\">99.67%<\/td>\n<td width=\"380\">Ubiquitin-specific protease 7 (USP7) inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3100<\/td>\n<td width=\"375\">(+)-MK 801<\/td>\n<td width=\"159\">70449-94-4<\/td>\n<td width=\"79\">99.38%<\/td>\n<td width=\"380\">Potent NMDA antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3104<\/td>\n<td width=\"375\">(E)-2-Decenoic acid<\/td>\n<td width=\"159\">334-49-6<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Fatty acid identified in royal jelly<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3108<\/td>\n<td width=\"375\">17 alpha-propionate<\/td>\n<td width=\"159\">19608-29-8<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Androgen antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3111<\/td>\n<td width=\"375\">1alpha, 25-Dihydroxy VD2-D6<\/td>\n<td width=\"159\">216244-04-1<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Deuterated form of vitamin D<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3115<\/td>\n<td width=\"375\">24, 25-Dihydroxy VD3<\/td>\n<td width=\"159\">40013-87-4<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Vitamin D analogue<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3118<\/td>\n<td width=\"375\">3,3&#8242;-Diindolylmethane<\/td>\n<td width=\"159\">1968-05-4<\/td>\n<td width=\"79\">99.69%<\/td>\n<td width=\"380\">Anticancer and antineoplastic agent<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3119<\/td>\n<td width=\"375\">360A<\/td>\n<td width=\"159\">794458-56-3<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">G-quadruplex structures inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3120<\/td>\n<td width=\"375\">360A iodide<\/td>\n<td width=\"159\">737763-37-0<\/td>\n<td width=\"79\">98.56%<\/td>\n<td width=\"380\">G-quadruplex structures inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3122<\/td>\n<td width=\"375\">PI4KIII beta inhibitor 3<\/td>\n<td width=\"159\">1245319-54-3<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">PI4KIII beta inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3123<\/td>\n<td width=\"375\">4&#8242;-Demethylepipodophyllotoxin<\/td>\n<td width=\"159\">6559-91-7<\/td>\n<td width=\"79\">99.32%<\/td>\n<td width=\"380\">Anti-cancer drug<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3124<\/td>\n<td width=\"375\">5-hydroxypyrazine-2-carboxylic acid<\/td>\n<td width=\"159\">34604-60-9<\/td>\n<td width=\"79\">99.15%<\/td>\n<td width=\"380\">Metabolite of pyrazinamide (PZA)<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3125<\/td>\n<td width=\"375\">5-Iodotubercidin<\/td>\n<td width=\"159\">24386-93-4<\/td>\n<td width=\"79\">98.34%<\/td>\n<td width=\"380\">Adenosine kinase inhibitor,potent<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3126<\/td>\n<td width=\"375\">5-R-Rivaroxaban<\/td>\n<td width=\"159\">865479-71-6<\/td>\n<td width=\"79\">99.49%<\/td>\n<td width=\"380\">Factor Xa (FXa) inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3130<\/td>\n<td width=\"375\">A 438079<\/td>\n<td width=\"159\">899507-36-9<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">P2X7 receptor antagonist,competitive and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3131<\/td>\n<td width=\"375\">A 438079 hydrochloride<\/td>\n<td width=\"159\">899431-18-6<\/td>\n<td width=\"79\">99.59%<\/td>\n<td width=\"380\">P2X7 receptor antagonist,competitive and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3132<\/td>\n<td width=\"375\">A 77-01<\/td>\n<td width=\"159\">607737-87-1<\/td>\n<td width=\"79\">99.50%<\/td>\n<td width=\"380\">Potent ALK5 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3133<\/td>\n<td width=\"375\">A 83-01<\/td>\n<td width=\"159\">909910-43-6<\/td>\n<td width=\"79\">99.24%<\/td>\n<td width=\"380\">ALK-5 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3134<\/td>\n<td width=\"375\">A-317491<\/td>\n<td width=\"159\">475205-49-3<\/td>\n<td width=\"79\">98.53%<\/td>\n<td width=\"380\">P2X3 and P2X2\/3 receptor antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3135<\/td>\n<td width=\"375\">A-443654<\/td>\n<td width=\"159\">552325-16-3<\/td>\n<td width=\"79\">99.79%<\/td>\n<td width=\"380\">Akt inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3136<\/td>\n<td width=\"375\">A-740003<\/td>\n<td width=\"159\">861393-28-4<\/td>\n<td width=\"79\">98.24%<\/td>\n<td width=\"380\">P2X7 receptor antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3138<\/td>\n<td width=\"375\">A-867744<\/td>\n<td width=\"159\">1000279-69-5<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Allosteric Modulator<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3139<\/td>\n<td width=\"375\">Abacavir<\/td>\n<td width=\"159\">136470-78-5<\/td>\n<td width=\"79\">99.89%<\/td>\n<td width=\"380\">Inhibitor of HIV reverse transcriptase<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3142<\/td>\n<td width=\"375\">Acamprosate calcium<\/td>\n<td width=\"159\">77337-73-6<\/td>\n<td width=\"79\">99.78%<\/td>\n<td width=\"380\">GABA receptor agonist and modulator of glutamatergic systems<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3143<\/td>\n<td width=\"375\">Adarotene<\/td>\n<td width=\"159\">496868-77-0<\/td>\n<td width=\"79\">99.24%<\/td>\n<td width=\"380\">Apoptosis inducer\/DNA damage agent<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3145<\/td>\n<td width=\"375\">Afatinib dimaleate<\/td>\n<td width=\"159\">850140-73-7<\/td>\n<td width=\"79\">99.49%<\/td>\n<td width=\"380\">EGFR inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3146<\/td>\n<td width=\"375\">AGI-6780<\/td>\n<td width=\"159\">1432660-47-3<\/td>\n<td width=\"79\">98.63%<\/td>\n<td width=\"380\">IDH2\/R140Q mutation inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3147<\/td>\n<td width=\"375\">AH 6809<\/td>\n<td width=\"159\">33458-93-4<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">EP and DP receptor antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3148<\/td>\n<td width=\"375\">AIM-100<\/td>\n<td width=\"159\">873305-35-2<\/td>\n<td width=\"79\">98.95%<\/td>\n<td width=\"380\">Ack1 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3149<\/td>\n<td width=\"375\">AKT inhibitor VIII<\/td>\n<td width=\"159\">612847-09-3<\/td>\n<td width=\"79\">99.73%<\/td>\n<td width=\"380\">Allosteric Akt kinase inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3151<\/td>\n<td width=\"375\">Alarelin Acetate<\/td>\n<td width=\"159\">79561-22-1<\/td>\n<td width=\"79\">99.88%<\/td>\n<td width=\"380\">Synthetic GnRH agonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3153<\/td>\n<td width=\"375\">Aliskiren<\/td>\n<td width=\"159\">173334-57-1<\/td>\n<td width=\"79\">98.95%<\/td>\n<td width=\"380\">Direct renin inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3155<\/td>\n<td width=\"375\">ALK inhibitor 2<\/td>\n<td width=\"159\">761438-38-4<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">ALK inhibitor, novel and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3156<\/td>\n<td width=\"375\">Alogliptin Benzoate<\/td>\n<td width=\"159\">850649-62-6<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">DPP-4 inhibitor,selective and potent,antidiabetic drug<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3157<\/td>\n<td width=\"375\">Alosetron<\/td>\n<td width=\"159\">122852-42-0<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">5-HT3 receptor antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3159<\/td>\n<td width=\"375\">Alosetron Hydrochloride<\/td>\n<td width=\"159\">122852-69-1<\/td>\n<td width=\"79\">98.91%<\/td>\n<td width=\"380\">5-HT3 receptor antagonist,potent and highly selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3162<\/td>\n<td width=\"375\">Alvimopan<\/td>\n<td width=\"159\">156053-89-3<\/td>\n<td width=\"79\">99.67%<\/td>\n<td width=\"380\">Mu-opioid receptors antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3163<\/td>\n<td width=\"375\">Alvimopan dihydrate<\/td>\n<td width=\"159\">170098-38-1<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">\u03bc-opioid receptor antagonist,peripherally acting<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3165<\/td>\n<td width=\"375\">ALW-II-41-27<\/td>\n<td width=\"159\">1186206-79-0<\/td>\n<td width=\"79\">97.45%<\/td>\n<td width=\"380\">Eph receptor inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3166<\/td>\n<td width=\"375\">AM095<\/td>\n<td width=\"159\">1345614-59-6<\/td>\n<td width=\"79\">98.14%<\/td>\n<td width=\"380\">Potent LPA1 receptor antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3167<\/td>\n<td width=\"375\">AM-095 free base<\/td>\n<td width=\"159\">1228690-36-5<\/td>\n<td width=\"79\">98.12%<\/td>\n<td width=\"380\">Potent LPA1 receptor antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3169<\/td>\n<td width=\"375\">AM679<\/td>\n<td width=\"159\">1206880-66-1<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">FLAP inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3170<\/td>\n<td width=\"375\">AM966<\/td>\n<td width=\"159\">1228690-19-4<\/td>\n<td width=\"79\">99.69%<\/td>\n<td width=\"380\">LPA1 antagonist, oral active, high affinity, selective,<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3171<\/td>\n<td width=\"375\">Amadacycline<\/td>\n<td width=\"159\">389139-89-3<\/td>\n<td width=\"79\">99.46%<\/td>\n<td width=\"380\">Tetracycline antibiotic<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3173<\/td>\n<td width=\"375\">AMD-070<\/td>\n<td width=\"159\">558447-26-0<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">CXCR4 antagonist,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3174<\/td>\n<td width=\"375\">AMD-070 hydrochloride<\/td>\n<td width=\"159\">880549-30-4<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">CXCR4 antagonist,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3176<\/td>\n<td width=\"375\">Ampalex<\/td>\n<td width=\"159\">154235-83-3<\/td>\n<td width=\"79\">98.54%<\/td>\n<td width=\"380\">Ampakine and nootropic<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3177<\/td>\n<td width=\"375\">AN-2690<\/td>\n<td width=\"159\">174671-46-6<\/td>\n<td width=\"79\">98.60%<\/td>\n<td width=\"380\">Antifungal agent<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3178<\/td>\n<td width=\"375\">AN-2728<\/td>\n<td width=\"159\">906673-24-3<\/td>\n<td width=\"79\">99.33%<\/td>\n<td width=\"380\">PDE4 inhibitor,anti-inflammatory compound<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3179<\/td>\n<td width=\"375\">Anamorelin<\/td>\n<td width=\"159\">249921-19-5<\/td>\n<td width=\"79\">99.68%<\/td>\n<td width=\"380\">Ghrelin receptor agonist, synthetic, orally active<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3182<\/td>\n<td width=\"375\">Anguizole<\/td>\n<td width=\"159\">442666-98-0<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Inhibitor of HCV replication<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3184<\/td>\n<td width=\"375\">AR-A014418<\/td>\n<td width=\"159\">487021-52-3<\/td>\n<td width=\"79\">98.34%<\/td>\n<td width=\"380\">GSK3\u03b2 inhibitor, ATP-competitive and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3185<\/td>\n<td width=\"375\">AR-C155858<\/td>\n<td width=\"159\">496791-37-8<\/td>\n<td width=\"79\">99.52%<\/td>\n<td width=\"380\">MCT1 and MCT2 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3188<\/td>\n<td width=\"375\">ARRY-520 R enantiomer<\/td>\n<td width=\"159\">885060-08-2<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">KSP inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3189<\/td>\n<td width=\"375\">AS 602801<\/td>\n<td width=\"159\">848344-36-5<\/td>\n<td width=\"79\">98.72%<\/td>\n<td width=\"380\">Jun Kinase Inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3190<\/td>\n<td width=\"375\">ASC-J9<\/td>\n<td width=\"159\">52328-98-0<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">AR degradation enhancer,antiumor agent<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3191<\/td>\n<td width=\"375\">Ascomycin(FK 520)<\/td>\n<td width=\"159\">104987-12-4<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Macrolide immunosuppressant,FK-520 analog<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3192<\/td>\n<td width=\"375\">Asenapine hydrochloride<\/td>\n<td width=\"159\">1412458-61-7<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Atypical antipsychotic<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3193<\/td>\n<td width=\"375\">ASP3026<\/td>\n<td width=\"159\">1097917-15-1<\/td>\n<td width=\"79\">99.38%<\/td>\n<td width=\"380\">ALK inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3194<\/td>\n<td width=\"375\">AST 487<\/td>\n<td width=\"159\">630124-46-8<\/td>\n<td width=\"79\">99.29%<\/td>\n<td width=\"380\">RET kinase inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3195<\/td>\n<td width=\"375\">Asunaprevir (BMS-650032)<\/td>\n<td width=\"159\">630420-16-5<\/td>\n<td width=\"79\">99.80%<\/td>\n<td width=\"380\">NS3 protease inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3196<\/td>\n<td width=\"375\">AT-101<\/td>\n<td width=\"159\">90141-22-3<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">BH3-mimetic,gossypol enantiomer<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3197<\/td>\n<td width=\"375\">AT7519 Hydrochloride<\/td>\n<td width=\"159\">902135-91-5<\/td>\n<td width=\"79\">99.80%<\/td>\n<td width=\"380\">Multi-CDK inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3198<\/td>\n<td width=\"375\">AT7519 trifluoroacetate<\/td>\n<td width=\"159\">1431697-85-6<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">CDK\/cyclin inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3199<\/td>\n<td width=\"375\">AT7867 dihydrochloride<\/td>\n<td width=\"159\">1431697-86-7<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Akt1 and p70S6K\/PKA inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3201<\/td>\n<td width=\"375\">Atrasentan hydrochloride<\/td>\n<td width=\"159\">195733-43-8<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Endothelin receptor antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3202<\/td>\n<td width=\"375\">Avermectin B1<\/td>\n<td width=\"159\">71751-41-2<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Insecticide<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3206<\/td>\n<td width=\"375\">AVL-292<\/td>\n<td width=\"159\">1202757-89-8<\/td>\n<td width=\"79\">98.27%<\/td>\n<td width=\"380\">Btk inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3208<\/td>\n<td width=\"375\">Avosentan<\/td>\n<td width=\"159\">290815-26-8<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">ETA receptor antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3209<\/td>\n<td width=\"375\">AXL1717<\/td>\n<td width=\"159\">477-47-4<\/td>\n<td width=\"79\">98.07%<\/td>\n<td width=\"380\">IGF-1R inhibitor,orally active<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3210<\/td>\n<td width=\"375\">AZ20<\/td>\n<td width=\"159\">1233339-22-4<\/td>\n<td width=\"79\">99.93%<\/td>\n<td width=\"380\">ATR inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3214<\/td>\n<td width=\"375\">AZD1152<\/td>\n<td width=\"159\">722543-31-9<\/td>\n<td width=\"79\">98.78%<\/td>\n<td width=\"380\">Aurora B kinase inhibitor,highly potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3215<\/td>\n<td width=\"375\">AZD7687<\/td>\n<td width=\"159\">1166827-44-6<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">DGAT inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3216<\/td>\n<td width=\"375\">Balaglitazone<\/td>\n<td width=\"159\">199113-98-9<\/td>\n<td width=\"79\">99.62%<\/td>\n<td width=\"380\">PPAR-\u03b3 partial agonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3217<\/td>\n<td width=\"375\">Balapiravir<\/td>\n<td width=\"159\">690270-29-2<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Polymerase inhibitor,anti-HCV<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3218<\/td>\n<td width=\"375\">BAM7<\/td>\n<td width=\"159\">331244-89-4<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">BAX activator,direct and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3219<\/td>\n<td width=\"375\">BAN ORL 24<\/td>\n<td width=\"159\">475150-69-7<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">NOP receptor antagonist, potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3220<\/td>\n<td width=\"375\">Bardoxolone<\/td>\n<td width=\"159\">218600-44-3<\/td>\n<td width=\"79\">99.55%<\/td>\n<td width=\"380\">Once-a-day treatment for CKD<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3221<\/td>\n<td width=\"375\">Bardoxolone methyl<\/td>\n<td width=\"159\">218600-53-4<\/td>\n<td width=\"79\">98.75%<\/td>\n<td width=\"380\">IKK inhibitor, potent antioxidant inflammation modulator<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3222<\/td>\n<td width=\"375\">Baricitinib phosphate<\/td>\n<td width=\"159\">1187595-84-1<\/td>\n<td width=\"79\">99.59%<\/td>\n<td width=\"380\">JAK1\/JAK2 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3227<\/td>\n<td width=\"375\">BAY 61-3606<\/td>\n<td width=\"159\">732983-37-8<\/td>\n<td width=\"79\">98.45%<\/td>\n<td width=\"380\">Syk Inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3228<\/td>\n<td width=\"375\">BAY 61-3606 dihydrochloride<\/td>\n<td width=\"159\">648903-57-5<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Syk tyrosine kinase inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3230<\/td>\n<td width=\"375\">Bay 65-1942 HCl salt<\/td>\n<td width=\"159\">600734-06-3<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">IKK\u03b2 kinase inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3232<\/td>\n<td width=\"375\">Bazedoxifene<\/td>\n<td width=\"159\">198481-32-2<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Estrogen receptor modulator<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3236<\/td>\n<td width=\"375\">Benfotiamine<\/td>\n<td width=\"159\">22457-89-2<\/td>\n<td width=\"79\">99.76%<\/td>\n<td width=\"380\">Drug for painful nerve condition<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3237<\/td>\n<td width=\"375\">Betulinic acid<\/td>\n<td width=\"159\">472-15-1<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Anti-HIV and antitumor compound,pentacyclic triterpenoid<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3238<\/td>\n<td width=\"375\">BEZ235 Tosylate<\/td>\n<td width=\"159\">1028385-32-1<\/td>\n<td width=\"79\">98.28%<\/td>\n<td width=\"380\">MTOR\/P13K inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3239<\/td>\n<td width=\"375\">B-HT 920<\/td>\n<td width=\"159\">36085-73-1<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">D2 receptor agonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3240<\/td>\n<td width=\"375\">BIBX 1382<\/td>\n<td width=\"159\">196612-93-8<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">EGFR inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3241<\/td>\n<td width=\"375\">Bilobalide<\/td>\n<td width=\"159\">33570-04-6<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Neuroprotective agent<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3242<\/td>\n<td width=\"375\">Bitopertin<\/td>\n<td width=\"159\">845614-11-1<\/td>\n<td width=\"79\">99.70%<\/td>\n<td width=\"380\">Glycine reuptake inhibitor(GlyT1)<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3244<\/td>\n<td width=\"375\">Bivalirudin Trifluoroacetate<\/td>\n<td width=\"159\">128270-60-0<\/td>\n<td width=\"79\">98.07%<\/td>\n<td width=\"380\">Reversible thrombin inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3246<\/td>\n<td width=\"375\">BMN-673 8R,9S<\/td>\n<td width=\"159\">1207456-00-5<\/td>\n<td width=\"79\">99.75%<\/td>\n<td width=\"380\">Inactive form of BMN 673, used as negative control<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3248<\/td>\n<td width=\"375\">BMS345541 hydrochloride<\/td>\n<td width=\"159\">547757-23-3<\/td>\n<td width=\"79\">99.57%<\/td>\n<td width=\"380\">IKK inhibitor,highly selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3250<\/td>\n<td width=\"375\">BMS-509744<\/td>\n<td width=\"159\">439575-02-7<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Itk inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3252<\/td>\n<td width=\"375\">BMS-599626 Hydrochloride<\/td>\n<td width=\"159\">873837-23-1<\/td>\n<td width=\"79\">99.58%<\/td>\n<td width=\"380\">EGFR\/HER2 inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3253<\/td>\n<td width=\"375\">BMS-626529<\/td>\n<td width=\"159\">701213-36-7<\/td>\n<td width=\"79\">98.01%<\/td>\n<td width=\"380\">HIV-1 attachment inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3254<\/td>\n<td width=\"375\">BMS-663068<\/td>\n<td width=\"159\">864953-29-7<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">HIV-1 attachment inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3256<\/td>\n<td width=\"375\">BMS-690514<\/td>\n<td width=\"159\">859853-30-8<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">HER\/EGFR inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3257<\/td>\n<td width=\"375\">BMS-790052 dihydrochloride<\/td>\n<td width=\"159\">1009119-65-6<\/td>\n<td width=\"79\">99.81%<\/td>\n<td width=\"380\">HCV NS5A inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3258<\/td>\n<td width=\"375\">BMS-833923<\/td>\n<td width=\"159\">1059734-66-5<\/td>\n<td width=\"79\">99.84%<\/td>\n<td width=\"380\">Smoothened inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3259<\/td>\n<td width=\"375\">BMS-927711<\/td>\n<td width=\"159\">1289023-67-1<\/td>\n<td width=\"79\">98.99%<\/td>\n<td width=\"380\">CGRP receptor antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3260<\/td>\n<td width=\"375\">BMX-IN-1<\/td>\n<td width=\"159\">1431525-23-3<\/td>\n<td width=\"79\">97.99%<\/td>\n<td width=\"380\">BMX (also termed ETK) kinase inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3261<\/td>\n<td width=\"375\">Boceprevir<\/td>\n<td width=\"159\">394730-60-0<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">HCV protease inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3263<\/td>\n<td width=\"375\">BRAF inhibitor<\/td>\n<td width=\"159\">918505-61-0<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Potent B-raf inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3264<\/td>\n<td width=\"375\">B-Raf inhibitor<\/td>\n<td width=\"159\">1315330-11-0<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">A B-Raf inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3265<\/td>\n<td width=\"375\">Brassinolide<\/td>\n<td width=\"159\">72962-43-7<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Plant growth regulator<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3266<\/td>\n<td width=\"375\">BS-181<\/td>\n<td width=\"159\">1092443-52-1<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">CDK7 inhibitor,highly selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3268<\/td>\n<td width=\"375\">CAL-130 Hydrochloride<\/td>\n<td width=\"159\">1431697-78-7<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">PI3K inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3270<\/td>\n<td width=\"375\">Calcifediol monohydrate<\/td>\n<td width=\"159\">63283-36-3<\/td>\n<td width=\"79\">99.43%<\/td>\n<td width=\"380\">Prehormone;vitamin D3 metabolite<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3271<\/td>\n<td width=\"375\">Calcipotriol<\/td>\n<td width=\"159\">112965-21-6<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Vitamin D3 analog,regulates cell differentiation and proliferation<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3275<\/td>\n<td width=\"375\">Calcium-Sensing Receptor Antagonists I<\/td>\n<td width=\"159\">478963-79-0<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">CaSR antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3276<\/td>\n<td width=\"375\">Canertinib dihydrochloride<\/td>\n<td width=\"159\">289499-45-2<\/td>\n<td width=\"79\">99.72%<\/td>\n<td width=\"380\">Pan-ErbB inhibitor, potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3277<\/td>\n<td width=\"375\">Capadenoson<\/td>\n<td width=\"159\">544417-40-5<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Adenosine A1 receptor agonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3278<\/td>\n<td width=\"375\">Nonivamide (Capsaicin Analog)<\/td>\n<td width=\"159\">2444-46-4<\/td>\n<td width=\"79\">99.53%<\/td>\n<td width=\"380\">TRPV1 receptor agonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3279<\/td>\n<td width=\"375\">Capsazepine<\/td>\n<td width=\"159\">138977-28-3<\/td>\n<td width=\"79\">99.25%<\/td>\n<td width=\"380\">TRPV1 ion channel antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3282<\/td>\n<td width=\"375\">Cariprazine<\/td>\n<td width=\"159\">839712-12-8<\/td>\n<td width=\"79\">99.19%<\/td>\n<td width=\"380\">D2\/D3 partial agonist,antipsychotic drug<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3284<\/td>\n<td width=\"375\">Cathepsin S inhibitor<\/td>\n<td width=\"159\">1373215-15-6<\/td>\n<td width=\"79\">98.33%<\/td>\n<td width=\"380\">Blocks MHCII antigen presentation<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3285<\/td>\n<td width=\"375\">CB 300919<\/td>\n<td width=\"159\">289715-28-2<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Potential therapy for ovarian cancer<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3286<\/td>\n<td width=\"375\">CB30865<\/td>\n<td width=\"159\">206275-15-2<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Nampt inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3287<\/td>\n<td width=\"375\">CC-401 hydrochloride<\/td>\n<td width=\"159\">1438391-30-0<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">JNK inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3288<\/td>\n<td width=\"375\">CC-930<\/td>\n<td width=\"159\">899805-25-5<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">JNK inhibitor,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3289<\/td>\n<td width=\"375\">CCG-63802<\/td>\n<td width=\"159\">620112-78-9<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">RGS protein inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3290<\/td>\n<td width=\"375\">CCG-63808<\/td>\n<td width=\"159\">620113-73-7<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Reversible RGS inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3291<\/td>\n<td width=\"375\">CCT241533<\/td>\n<td width=\"159\">1262849-73-9<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Potent Chk2 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3292<\/td>\n<td width=\"375\">CCT241533 hydrochloride<\/td>\n<td width=\"159\">1431697-96-9<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">CHK2 kinase inhibitor, novel<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3293<\/td>\n<td width=\"375\">CDK inhibitor II<\/td>\n<td width=\"159\">1269815-17-9<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">CDK inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3294<\/td>\n<td width=\"375\">CDK9 inhibitor<\/td>\n<td width=\"159\">1415559-43-1<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">CDK9 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3295<\/td>\n<td width=\"375\">CDK9 inhibitor 2<\/td>\n<td width=\"159\">1263369-28-3<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">CDK9 inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3297<\/td>\n<td width=\"375\">CEP-32496 hydrochloride<\/td>\n<td width=\"159\">1227678-26-3<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">B-Raf\/C-Raf inhibitor,highly potent<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3298<\/td>\n<td width=\"375\">Cetirizine<\/td>\n<td width=\"159\">83881-51-0<\/td>\n<td width=\"79\">99.65%<\/td>\n<td width=\"380\">Antihistamine<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3300<\/td>\n<td width=\"375\">Cevimeline hydrochloride hemihydrate<\/td>\n<td width=\"159\">153504-70-2<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Agonist of muscarinic receptor (M1\/M3)<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3302<\/td>\n<td width=\"375\">CGI-1746<\/td>\n<td width=\"159\">910232-84-7<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Btk inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3303<\/td>\n<td width=\"375\">CGP60474<\/td>\n<td width=\"159\">164658-13-3<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">CDKs and PKC inhibitor, potent<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3304<\/td>\n<td width=\"375\">CGS 21680<\/td>\n<td width=\"159\">120225-54-9<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Adenosine A2 receptor agonists,potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3305<\/td>\n<td width=\"375\">CHAPS<\/td>\n<td width=\"159\">75621-03-3<\/td>\n<td width=\"79\">97.71%<\/td>\n<td width=\"380\">Zwitterionic detergent for membrane proteins,nondenaturing<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3306<\/td>\n<td width=\"375\">Chelerythrine Chloride<\/td>\n<td width=\"159\">3895-92-9<\/td>\n<td width=\"79\">99.36%<\/td>\n<td width=\"380\">PKC antagonist<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3307<\/td>\n<td width=\"375\">CHIR-090<\/td>\n<td width=\"159\">728865-23-4<\/td>\n<td width=\"79\">99.37%<\/td>\n<td width=\"380\">Potent LpxC inhibitor<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3308<\/td>\n<td width=\"375\">Choline Fenofibrate<\/td>\n<td width=\"159\">856676-23-8<\/td>\n<td width=\"79\">99.92%<\/td>\n<td width=\"380\">Choline salt of fenofibric acid<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3309<\/td>\n<td width=\"375\">CHR-6494<\/td>\n<td width=\"159\">1333377-65-3<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">Haspin inhibitor,potent ands selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3310<\/td>\n<td width=\"375\">chroman 1<\/td>\n<td width=\"159\">1273579-40-0<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">ROCK II inhibitor, highly potent and selective<\/td>\n<\/tr>\n<tr>\n<td width=\"96\">A3311<\/td>\n<td width=\"375\">CID-2858522<\/td>\n<td width=\"159\">758679-97-9<\/td>\n<td width=\"79\">98.00%<\/td>\n<td width=\"380\">NF-\u03baB pathway inhibitor<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u751f\u5316\u5206\u6790\u8a66\u5291\u7cfb\u5217\u5546\u54c1-&gt;&gt;3X (DYKDDDDK) Peptide APExBIO Techno [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":51043,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[5368,486],"tags":[4951],"_links":{"self":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/34258"}],"collection":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=34258"}],"version-history":[{"count":4,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/34258\/revisions"}],"predecessor-version":[{"id":51884,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/posts\/34258\/revisions\/51884"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=\/wp\/v2\/media\/51043"}],"wp:attachment":[{"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=34258"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=34258"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/biopioneer.com.tw\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=34258"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}